Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Arginine × Clear all

Phase

Status

Completed 11 Unknown 3 Suspended 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 35 Magnetic Resonance Spectroscopy 23 Cyclophosphamide 18 Biopsy 18 Vincristine 10 Paclitaxel 10 Nivolumab 10 Doxorubicin 9 Cisplatin 9 Prednisone 8 Bevacizumab 8 pembrolizumab 7 Rituximab 7 Radiotherapy 7 Etoposide 7 Azacitidine 7 venetoclax 6 Radiation 6 Gemcitabine 6 Fluorouracil 6 Drug Therapy 6 Docetaxel 6 Carboplatin 6 Radiosurgery 5 Oxaliplatin 5 Irinotecan 5 Injections 5 Capecitabine 5 prednylidene 4 fludarabine phosphate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07150806 2026-04-17

RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma

Ohio State University Comprehensive Cancer Center

Phase 1/2 Suspended

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡